Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹199Cr
Rev Gr TTM
Revenue Growth TTM
72.12%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

MKPL
VS
| Quarter | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | | | | | -24.8 | 147.0 | -42.7 | 57.9 | 100.5 | -3.7 | 126.8 |
| 72 | 13 | 65 | 78 | 54 | 31 | 38 | 133 | 109 | 31 | 87 |
Operating Profit Operating ProfitCr |
| 5.3 | 4.7 | 5.2 | 9.7 | 6.5 | 6.6 | 4.5 | 3.4 | 4.8 | 3.2 | 2.6 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 3 | 1 | 3 | 8 | 3 | 2 | 2 | 4 | 5 | 1 | 2 |
| 1 | 0 | 1 | 2 | 1 | 1 | 0 | 1 | 1 | 0 | 1 |
|
Growth YoY PAT Growth YoY% | | | | | -0.4 | 324.4 | -44.4 | -52.0 | 41.5 | -56.9 | 3.6 |
| 3.3 | 3.0 | 3.6 | 6.7 | 4.3 | 5.2 | 3.5 | 2.0 | 3.0 | 2.3 | 1.6 |
| 0.1 | 0.0 | 0.1 | 0.2 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 13.7 | 4.3 | -8.7 | 23.8 | 60.3 | -17.8 | 23.1 | -22.0 | 9.0 | 39.8 |
| 141 | 160 | 166 | 152 | 189 | 295 | 240 | 298 | 229 | 255 | 361 |
Operating Profit Operating ProfitCr |
| 2.9 | 3.0 | 3.2 | 3.2 | 2.5 | 5.1 | 6.1 | 5.4 | 6.8 | 4.6 | 3.6 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 2 |
Depreciation DepreciationCr | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
| 1 | 2 | 2 | 2 | 2 | 14 | 14 | 15 | 15 | 11 | 12 |
| 0 | 1 | 1 | 1 | 1 | 4 | 4 | 4 | 4 | 3 | 3 |
|
| | 36.5 | 44.7 | 15.2 | 10.6 | 471.8 | -2.0 | 7.4 | 2.5 | -25.1 | 1.1 |
| 0.5 | 0.6 | 0.8 | 1.1 | 0.9 | 3.3 | 4.0 | 3.5 | 4.6 | 3.1 | 2.3 |
| 3.0 | 4.0 | 0.0 | 0.0 | 0.1 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 1 | 3 | 4 | 4 | 4 | 4 | 4 | 13 | 38 | 38 | 38 |
| 3 | 2 | 11 | 13 | 15 | 25 | 35 | 37 | 24 | 32 | 36 |
Current Liabilities Current LiabilitiesCr | 28 | 30 | 29 | 29 | 34 | 34 | 44 | 50 | 34 | 59 | 4 |
Non Current Liabilities Non Current LiabilitiesCr | 8 | 12 | 12 | 2 | 4 | 5 | 3 | 4 | 1 | 2 | 2 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 32 | 39 | 50 | 42 | 53 | 64 | 82 | 99 | 86 | 119 | 67 |
Non Current Assets Non Current AssetsCr | 7 | 8 | 6 | 5 | 4 | 3 | 4 | 5 | 10 | 12 | 13 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | -4 | -4 | -12 | 6 | -4 | 6 | -10 | -6 | 32 | -16 |
Investing Cash Flow Investing Cash FlowCr | -2 | -1 | 0 | 0 | 0 | 0 | -2 | 0 | -6 | -1 |
Financing Cash Flow Financing Cash FlowCr | 6 | 5 | 12 | -7 | 4 | -5 | 12 | 6 | -27 | 18 |
|
Free Cash Flow Free Cash FlowCr | -6 | -5 | -12 | 7 | -4 | 5 | -12 | -6 | 27 | -18 |
| -585.7 | -363.4 | -842.6 | 386.5 | -246.0 | 53.3 | -99.4 | -53.7 | 289.1 | -192.1 |
CFO To EBITDA CFO To EBITDA% | -100.9 | -73.5 | -218.0 | 127.7 | -93.3 | 34.7 | -64.7 | -34.4 | 195.1 | -129.7 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 0 | 34 | 31 | 30 | 33 | 80 | 0 | 371 | 227 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 23.5 | 18.9 | 16.4 | 3.2 | 7.8 | 0.0 | 32.9 | 27.4 |
Price To Sales Price To Sales | 0.0 | 0.0 | 0.2 | 0.2 | 0.1 | 0.1 | 0.3 | 0.0 | 1.5 | 0.8 |
Price To Book Price To Book | 0.0 | 0.0 | 2.2 | 1.8 | 1.6 | 1.1 | 2.0 | 0.0 | 6.1 | 3.3 |
| 6.1 | 6.2 | 11.9 | 11.5 | 12.5 | 3.6 | 7.5 | 2.7 | 23.5 | 21.4 |
Profitability Ratios Profitability Ratios |
| 10.4 | 11.1 | 8.0 | 8.4 | 7.3 | 8.1 | 11.2 | 9.4 | 11.9 | 10.5 |
| 2.9 | 3.0 | 3.2 | 3.2 | 2.5 | 5.1 | 6.1 | 5.4 | 6.8 | 4.6 |
| 0.5 | 0.6 | 0.8 | 1.1 | 0.9 | 3.3 | 4.0 | 3.5 | 4.6 | 3.1 |
| 11.3 | 10.8 | 9.1 | 8.9 | 8.0 | 28.0 | 19.5 | 17.6 | 20.4 | 11.6 |
| 22.1 | 23.2 | 9.2 | 9.6 | 9.6 | 35.4 | 25.7 | 21.9 | 18.4 | 12.1 |
| 1.9 | 2.1 | 2.5 | 3.5 | 3.2 | 15.4 | 11.8 | 10.6 | 11.7 | 6.4 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
M. K. Proteins Limited is a vertically integrated Indian manufacturing and trading enterprise specializing in the edible oil industry. The company operates a sophisticated, mechanized refinery in **Ambala, Haryana**, producing high-quality vegetable refined oils and high-value by-products. Having successfully transitioned from the **NSE SME Emerge** platform to the **Main Board of the NSE and BSE** in **June 2023**, the company is currently scaling its operations to capture the shift from unbranded to organized branded oil consumption in India.
---
### Integrated Refining Operations and Product Portfolio
The company’s business model is centered on a single reportable segment: **Manufacturing of Vegetable Refined Oil**. Its competitive advantage lies in a completely mechanized refining process that ensures sustained levels of cleaning and monitoring to produce oils with controlled fiber and protein content, free from residue and ash.
* **Refined Oil Variants:** The portfolio includes **Rice Bran Oil, Sunflower Oil, Canola Oil, Soya Bean Oil,** and **Rice Bran Bleached Oil**.
* **By-product Commercialization:** The refining process yields several salable by-products, including **Rice Bran Fatty Acid Oil, Rice Bran Wax, Gums, and Spent Earth**, which contribute to diversified revenue streams.
* **Trading and Import Capabilities:** Beyond manufacturing, the company imports crude oils for internal processing and engages in the trading of both edible and non-edible oils to meet domestic demand. In **FY23**, the CIF value of imports stood at **Rs. 2,520.56 Lakhs**.
* **Geographic Focus:** The company is currently **100% domestic-focused**, reporting **zero export earnings** for the **2021-22** and **2022-23** periods.
---
### Strategic Growth Initiatives and Capital Expenditure
To maintain its market position in a fragmented industry, M. K. Proteins is aggressively investing in technology and distribution.
* **Technological Upgrades:** In **December 2023**, the Board approved a capital expenditure of **Rs. 5.90 Crores** for new **Vegetable Oil Refinery Equipment** to enhance final product quality and operational efficiency.
* **Market Expansion:** The company is targeting the **13%** of the Indian market still using unbranded/loose oil. Strategy involves improving direct coverage in rural India, which accounts for nearly **50%** of category volume.
* **Operational Resilience:** Despite price volatility in early **2023**, the company revived volumes in **H2 2023** by capitalizing on increased out-of-home consumption during India’s festival and wedding seasons.
* **Cost Efficiency:** The company utilizes indigenous technology to lower production costs and supplements government electricity with internal generation.
---
### Financial Performance and Capital Structure
M. K. Proteins has demonstrated a commitment to shareholder value through aggressive corporate actions and capital restructuring.
**Key Financial Metrics**
| Particulars (Rs. in Crore) | FY 2024-25 | FY 2023-24 |
| :--- | :--- | :--- |
| **Operational Revenue** | **268.18** | **246.02** |
| **Profit Before Tax (PBT)** | **11.45** | **15.47** |
| **Net Profit (PAT)** | **8.39** | **11.21** |
| **Total Equity** | **69.47** | **61.08** |
| **Total Debt** | **37.75** | **19.09** |
| **Debt-Equity Ratio** | **0.54** | **0.31** |
**Capital Restructuring History**
* **Stock Split (Nov 2023):** Sub-division of face value from **Rs. 10** to **Re. 1** per share to enhance liquidity.
* **Bonus Issue (March 2024):** Allotment of **25,02,48,000** shares in a **2:1** ratio. This followed a previous **2:1** bonus in **February 2023**.
* **Authorized Capital:** Increased from **Rs. 15 Crores** to **Rs. 40 Crores** in **March 2024** to accommodate growth.
* **Paid-up Capital:** Currently stands at **Rs. 37,53,72,000** (comprising **37,53,72,000** shares).
---
### Governance, Management, and Oversight
The company is managed by the **Kumar brothers** (**Parmod, Vinod, Parvind, and Raj Kumar**), who bring decades of industry experience.
* **Board Structure:** As of **March 31, 2025**, the board consists of **8 Directors**, including **4 Independent Directors**.
* **Key Leadership:** **Mr. Parmod Kumar** serves as the **Managing Director** and **Chief Operating Decision Maker (CODM)**.
* **Recent Appointments:** **Mr. Deepak Khetarpal** joined as an Independent Director in **August 2025**.
* **Auditor Transition:** In **August 2025**, the company transitioned from **M/s. KRA & Co.** to a local statutory audit firm to improve operational coordination and ensure timely regulatory compliance.
---
### Risk Framework and Mitigation Strategies
The edible oil sector is characterized by high volatility and regulatory sensitivity. M. K. Proteins manages these through a structured risk framework.
**1. Commodity and Supply Chain Risks**
* **Price Volatility:** A **1% increase** in commodity prices impacts profits by approximately **Rs. 2.72 Crores**.
* **Import Dependency:** India imports **1.6 crore metric tonnes** annually. The company is vulnerable to export policy shifts in **Indonesia and Malaysia**.
* **Climate Sensitivity:** Domestic oilseed production is **76% rain-fed**. In **July 2023**, extreme rainfall (**500mm**) caused a **19-day** operational shutdown at the Ambala facility due to flooding.
**2. Financial and Liquidity Risks**
* **Debt Management:** Current borrowings of **Rs. 36.92 Crore** (as of March 2025) are primarily **Secured Cash Credit Facilities** from **HDFC Bank** at interest rates of **9% to 9.23%**.
* **Interest Rate Sensitivity:** A **50 bps** change in rates impacts profit by **Rs. 9.54 Lakhs**.
* **Credit Risk:** Managed via an **Expected Credit Loss (ECL)** model and a focus on **advance payments**.
**3. Sectoral Challenges**
* **Regulatory Shifts:** Profitability is tied to the **Government of India’s** duty differentials between crude and refined oils and changes in **Minimum Support Prices (MSP)**.
* **Industry Inefficiencies:** The sector broadly suffers from **low capacity utilization** and **outdated technology**, which the company seeks to bypass through its mechanized refinery model.
---
### Market Outlook
The Indian branded edible oil market is valued at **Rs. 1,56,000 Crores** and is projected to reach a **90%** value share of the total market within five years. With global edible oil markets expected to reach **USD 190.88 Billion** by **2030** (**8.10% CAGR**), M. K. Proteins is positioned to leverage its increased capital base and modernized refining capacity to capture domestic volume growth.